Stock listing

Entera Bio Ltd.

Selected listing: ENTX · NASDAQ · USD · US

Entera Bio Ltd. (NASDAQ:ENTX), Health Technology. Latest release Oct 6, 2026: Entera Appoints Global BioPharma Executive Laura Hamill to Its Board…

ENTX:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:ENTX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Entera Bio Ltd.

Entera Bio Ltd. is a public company traded under the ticker ENTX in the American market. Entera Bio focuses on developing oral drug delivery systems for biologics, aiming to improve patient outcomes and expand treatment options.

Latest news from Entera Bio Ltd.

Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise

October 6, 2026

Correction: Entera to Participate in Upcoming Fall Investor Conferences

August 27, 2026

Entera to Participate in Upcoming Fall Investor Conferences

August 27, 2026

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

August 18, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

August 7, 2026

All Entera Bio Ltd. news →

Events

Replays

Entera Bio Ltd. (ENTX) Q1 2022 Earnings Call
Wed, May 18, 2022 · 08:00 AM ET
Watch
Entera Bio Ltd. (ENTX) Q4 2021 Earnings Call
Tue, Mar 08, 2022 · 08:30 AM ET
Watch
Entera Bio Ltd. (ENTX) Q2 2021 Earnings Call
Mon, Aug 16, 2021 · 08:30 AM ET
Watch

Research Entera Bio Ltd.

Entera Bio Ltd. company profile

View the public company page for Entera Bio Ltd. on 6ix.

Entera Bio Ltd. news

Read company news and market updates connected to Entera Bio Ltd..

Entera Bio Ltd. investor events

Find investor webinars, events, and replay context for Entera Bio Ltd..